评估非酒精性脂肪性肝炎的预后？是时候认真对待了。 - Suppr

Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.

作者信息

Ratziu Vlad, Poynard Thierry

出版信息

Hepatology. 2006 Oct;44(4):802-5. doi: 10.1002/hep.21391.

DOI:10.1002/hep.21391

PMID:17006914

Abstract

摘要

相似文献

Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.

Hepatology. 2006 Oct;44(4):802-5. doi: 10.1002/hep.21391.

[Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].

Ned Tijdschr Geneeskd. 2005 Feb 5;149(6):289-94.

Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.

Clin Liver Dis. 2005 Nov;9(4):617-34, vi. doi: 10.1016/j.cld.2005.07.002.

NASH and HCC.

Clin Liver Dis. 2009 Nov;13(4):631-47. doi: 10.1016/j.cld.2009.07.007.

Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.

Hepatology. 2010 Dec;52(6):2248-9. doi: 10.1002/hep.23838. Epub 2010 Jul 29.

Hepatocellular carcinoma and NASH.

J Gastroenterol. 2004;39(4):409-11. doi: 10.1007/s00535-004-1332-y.

[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?].

Gastroenterol Clin Biol. 2003 Oct;27(10):869-75.

Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.

J Gastroenterol Hepatol. 2006 Dec;21(12):1865-6. doi: 10.1111/j.1440-1746.2006.04282.x.

Preface.

Clin Liver Dis. 2009 Nov;13(4):xiii-xiv. doi: 10.1016/j.cld.2009.08.001.

Primary liver cancers with nonalcoholic steatohepatitis.

Eur J Gastroenterol Hepatol. 2007 Oct;19(10):827-34. doi: 10.1097/MEG.0b013e3282748ef2.

引用本文的文献

Meat consumption and risk of hepatobiliary cancers in the National Institutes of Health-AARP Diet and Health Study.

JNCI Cancer Spectr. 2025 Jul 1;9(4). doi: 10.1093/jncics/pkaf068.

Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice.

Front Pharmacol. 2025 Jan 31;15:1503247. doi: 10.3389/fphar.2024.1503247. eCollection 2024.

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.

Nutrients. 2021 Dec 24;14(1):76. doi: 10.3390/nu14010076.

Identifying Lipid Metabolites Influenced by Oleic Acid Administration Using High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipidomics.

ACS Omega. 2020 Apr 29;5(20):11314-11323. doi: 10.1021/acsomega.9b04402. eCollection 2020 May 26.

Dietary factors can protect against liver cancer development.

World J Hepatol. 2017 Jan 28;9(3):119-125. doi: 10.4254/wjh.v9.i3.119.

Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience.

J Clin Exp Hepatol. 2016 Dec;6(4):291-296. doi: 10.1016/j.jceh.2016.08.006. Epub 2016 Aug 28.

Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway.

Sci Rep. 2016 Nov 30;6:38138. doi: 10.1038/srep38138.

Mapping liver fat female-dependent quantitative trait loci in collaborative cross mice.

Mamm Genome. 2016 Dec;27(11-12):565-573. doi: 10.1007/s00335-016-9658-3. Epub 2016 Jul 15.

Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice.

Sci Rep. 2016 Jan 6;6:18899. doi: 10.1038/srep18899.

Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease.

Evid Based Complement Alternat Med. 2015;2015:980345. doi: 10.1155/2015/980345. Epub 2015 Oct 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献